152 related articles for article (PubMed ID: 6319793)
1. Histologic and cell surface antigen studies of hematopoietic tumors induced by Cas-Br-M murine leukemia virus.
Fredrickson TN; Langdon WY; Hoffman PM; Hartley JW; Morse HC
J Natl Cancer Inst; 1984 Feb; 72(2):447-54. PubMed ID: 6319793
[TBL] [Abstract][Full Text] [Related]
2. Analysis of neoplasms induced by Cas-Br-M MuLV tumor extracts.
Holmes KL; Langdon WY; Fredrickson TN; Coffman RL; Hoffman PM; Hartley JW; Morse HC
J Immunol; 1986 Jul; 137(2):679-88. PubMed ID: 3014001
[TBL] [Abstract][Full Text] [Related]
3. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
[TBL] [Abstract][Full Text] [Related]
4. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
[TBL] [Abstract][Full Text] [Related]
5. Phenylhydrazine stimulates lymphopoiesis and accelerates Abelson murine leukemia virus-induced pre-B cell lymphomas.
Klinken SP; Holmes KL; Fredrickson TN; Erner SM; Morse HC
J Immunol; 1987 Nov; 139(9):3091-8. PubMed ID: 2822804
[TBL] [Abstract][Full Text] [Related]
6. Wild mouse ecotropic murine leukemia virus infection of inbred mice: dual-tropic virus expression precedes the onset of paralysis and lymphoma.
Hoffman PM; Davidson WF; Ruscetti SK; Chused TM; Morse HC
J Virol; 1981 Aug; 39(2):597-602. PubMed ID: 6268845
[TBL] [Abstract][Full Text] [Related]
7. Biological characterization and molecular cloning of murine C-type retroviruses derived from the TSZ complex from mainland China.
Bundy LM; Ru M; Zheng BF; Cheng L; Pattengale PK; Portis JL; Fan H
Virology; 1995 Oct; 212(2):367-82. PubMed ID: 7571406
[TBL] [Abstract][Full Text] [Related]
8. Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice.
Brightman BK; Okimoto M; Kulkarni V; Lander JK; Fan H
Virology; 1998 Mar; 242(1):60-7. PubMed ID: 9501051
[TBL] [Abstract][Full Text] [Related]
9. Induction of B-tropic and N-tropic murine leukemia virus from B10.BR/SgLi mouse embryo cell lines by 5-iodo-2'-deoxyuridine.
Moll B; Hartley JW; Rowe WP
J Natl Cancer Inst; 1979 Jul; 63(1):213-7. PubMed ID: 221716
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
Nazarov V; Hilbert D; Wolff L
Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
[TBL] [Abstract][Full Text] [Related]
11. Generation and pathogenicity of an NB-tropic SL3-3 murine leukemia virus.
Thomas CY; Nuckols JD; Murphy C; Innes D
Virology; 1993 Apr; 193(2):1013-7. PubMed ID: 8384741
[TBL] [Abstract][Full Text] [Related]
12. Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.
Sørensen KD; Quintanilla-Martinez L; Kunder S; Schmidt J; Pedersen FS
J Virol; 2004 Dec; 78(23):13216-31. PubMed ID: 15542674
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous tumors of NFS mice congenic for ecotropic murine leukemia virus induction loci.
Fredrickson TN; Morse HC; Rowe WP
J Natl Cancer Inst; 1984 Aug; 73(2):521-4. PubMed ID: 6087009
[TBL] [Abstract][Full Text] [Related]
14. Distribution of Fv-4 resistant gene product in Friend leukemia virus-resistant Fv-4r mouse strain.
Kitagawa M; Aizawa S; Kamisaku H; Sado T; Ikeda H; Hirokawa K
Exp Hematol; 1996 Oct; 24(12):1423-31. PubMed ID: 8913289
[TBL] [Abstract][Full Text] [Related]
15. Enhancer mutations of Akv murine leukemia virus inhibit the induction of mature B-cell lymphomas and shift disease specificity towards the more differentiated plasma cell stage.
Sørensen KD; Kunder S; Quintanilla-Martinez L; Sørensen J; Schmidt J; Pedersen FS
Virology; 2007 May; 362(1):179-91. PubMed ID: 17258785
[TBL] [Abstract][Full Text] [Related]
16. Cell surface antigen phenotypes of MCF-induced thymic lymphomas in AKR mice.
Yetter RA; Morse HC
J Immunol; 1984 May; 132(5):2644-8. PubMed ID: 6609203
[TBL] [Abstract][Full Text] [Related]
17. Effect of administration of diethylcarbamazine on murine leukemia virus (Cas-Br-M) infected mice.
Kitchen LW; Mather FJ; Chapple FE; Bilello JA
J Clin Lab Immunol; 1990 Nov; 33(3):97-105. PubMed ID: 1967004
[TBL] [Abstract][Full Text] [Related]
18. Effect of non-H-2-linked genes on anti-virus immune responses and long-term survival in mice persistently infected with E-55+ murine leukemia virus.
Avidan N; Tumas-Brundage KM; Sieck TG; Prystowsky MB; Blank KJ
Virology; 1995 Aug; 211(2):507-15. PubMed ID: 7645254
[TBL] [Abstract][Full Text] [Related]
19. Surface antigen expressed in hematopoietic cells derived from Fv-4r mouse strains.
Yoshikura H; Odaka T
J Natl Cancer Inst; 1982 Jun; 68(6):1005-9. PubMed ID: 6283223
[TBL] [Abstract][Full Text] [Related]
20. Host genetic determinants of neurological disease induced by Cas-Br-M murine leukemia virus.
Hoffman PM; Morse HC
J Virol; 1985 Jan; 53(1):40-3. PubMed ID: 2981360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
